The present study evaluated the effect of the aqueous extract from leaves of E. speciosa on some physiological and biochemical parameters of reproduction and the onset of puberty in pregnant mare serum gonadotropin (PMSG)-primed immature female rats. High pressure liquid chromatography (HPLC) was used to quantify the phenolic compounds in the methanol/methylene chloride (1:1) extract, the ethanolic and ethyl acetate fractions and the aqueous residue of E. speciosa. E. speciosa (0, 8, 32 or 64 mg/kg) were administered for 15 days to 24 non-PMSG-primed and 24 primed rats with 0.01 IU of PMSG. At the end of the treatment period, animal were sacrificed and their body, ovarian, uterine weight, ovarian protein or cholesterol level, as well as data on puberty onset were recorded. Of the 16 polyphenolic compounds quantitatively revealed in the extracts and fractions of E. speciosa after HPLC analysis, quercetin, rutin, apigenin and eugenol were the most abundant. Non-primed rats showed a significant increase (P < 0.05) in the uterine relative weight at the dose of 8 mg/kg when compared with the other treatments. The uterine proteins and the ovarian cholesterol (P < 0.05), respectively, showed a reduction at doses of 64 mg/kg and 32 mg/kg in non-primed rats. However in PMSG-primed rats, a significant decrease (P < 0.05) was observed in ovarian cholesterol at 64 mg/kg. In conclusion, E. speciosa potentializes the PMSG-inducing effect on folliculogenesis in PMSG-primed rats.

Artificial insemination protocols depend on efficient behavioral estrus detection and insemination time in Angora goat. Therefore, we aim to determine the accuracy of an estrus scoring system in Angora goats with different PMSG doses during the breeding season. Does (n: 260) were randomly divided into three groups: group-1 (n: 93), group-2 (n: 85) and group-3 (n: 82). All animals received an intravaginal sponge on day 0 for 11 days, and on the day of sponge insertion 150 μg prostaglandin F2Α was administered. Pregnant mare’s serum gonadotropin was injected 300, 400 and 500 IU intramuscularly 24 h before sponge removal to groups 1, 2 and 3, respectively. Estrus signs were detected with a teaser buck, 24 h after sponge removal according to a visual scoring system. Artificial insemination was performed with 0.25 ml fresh diluted semen at 43 to 45 h after sponge removal. Differences were observed within PMSG groups in terms of standing, tail wagging, courtship behavior, vaginal discharge and vaginal hyperemia (P<0.001). Nevertheless, the most accurate indicators of estrus that result in pregnancy were tail wagging and courtship behavior followed by standing estrus (P<0.05). According to the results obtained, 300 IU PMSG dose is sufficient, both to inseminate at a fixed time (43 to 45 h after sponge removal) and to record the estrus behavior by teaser male 24 h after sponge removal. Higher PMSG doses (400 to 500 IU) altered the timing of ovulation; specifically, 500 IU dose shortened the duration of estrus behaviors. In conclusion, even though the different doses of PMSG displayed similar effects on estrus synchronization and pregnancy rates, we concluded that tail wagging, courtship behavior and standing heat are the most reliable estrus signs for artificial insemination in Angora goat.

Gonadotropins are the key regulators of ovarian follicles development. They are applied in therapeutic practice in assisted reproductive technology clinics. In the present review we discuss the basic gonadotropic hormones – recombinant human follicle-stimulating hormone, its derivatives, luteinizing hormone and gonadotropin serum of pregnant mares, their origin, and application in ovarian follicle systems in in vitro culture systems.

It is well established that estrogen and progesterone are critical endogenous hormones that are essential for implantation and pregnancy in females. However, the distribution of estrogen receptor α (ERα) and progesterone receptor (PR) in female reproductive tracts is elusive. Herein, we report that after serial treatments with pregnant mare's serum gonadotrophin (PMSG) with or without anti-PMSG (AP), mice could regulate the distribution of ERα and PR in the murine ovary, oviduct and uterus and the level of estradiol in serum. ERα and PR regulation by PMSG and anti-PMSG was estrous cycle-dependent and critical for promoting the embryo-implantation period. Furthermore, our results suggested that AP-42 h treatment is more effective than the other treatments. In contrast, other treatment groups also affected the distribution of ERα and PR in mouse reproductive tracts. Thus, we found that anti-PMSG has the potential to restore the distribution of ERα and PR, which could effectively reduce the negative impact of residual estrogen caused by the normal superovulation effect of PMSG in mice.

Two experiments were performed to examine the effects of immunoneutralizing PMSG at the onset of oestrus on the reproductive performance of sows. In experiment 1, 12 multiparous sows received 750 i.u. PMSG at weaning and six sozus acted as controls and were injected with saline. At 84 h after PMSG injection, all sows received an injection of 500 i.u. human chorionic gonadotropin (hCG) and six of the PMSG-treated sows also received an injection of 750 i.u. of a monoclonal anti-PMSG serum. The ovaries of all sows were examined by real time ultrasonography at 60-min intervals from 36 to 48 h after hCG injection for evidence of ovulation. In sows observed to ovulate, there was no significant effect of treatment on the interval from hCG injection to the start of ovulation, the duration of ovulation or subsequent litter size. In experiment 2, 253 primiparous sows received injections at weaning of 750 i.u. PMSG (no. = 134), 400 i.u. PMSG plus 200 i.u. hCG (no. = 69) or served as controls (no. = 50). At breeding, 67 of the PMSG-treated sows received an injection of 750 i.u. of monoclonal anti-PMSG serum.

More gonadotropin-treated than control sows were bred by 7 days after weaning (P < 0·05). Farrowing rates were higher in sows receiving the PMSG followed by anti-PMSG and PMSG plus hCG than in controls (P < 0·05), with those receiving PMSG alone being intermediate. There was no effect of treatment on subsequent litter sizes. These data indicate that the reproductive performance of primiparous sows may be improved by gonadotropin administration at the time of weaning. However, there was no advantage to using any particular hormone combination or anti-PMSG.

In four experiments, 189 gilts either received PMSG antiserum around the time of a PMSG- (experiments 1, 2 and 3) or PMSG/hCG-induced (experiment 4) oestrus or served as controls. Ovulation rates were not affected by treatment. There was no treatment effect on pregnancy rate (experiments 2, 3 and 4). In experiment 2, numbers of embryos in PMSG-treated control gilts were quite low and were higher (P < 0·05) in those gilts subsequently receiving anti-PMSG treatment. In experiment 3, the mean number of embryos in control gilts were higher than in experiment 2 and there was no effect of immunoneutralization of PMSG. No treatment effect was evident in PMSG/hCG treated gilts (experiment 4). These data indicate that the immunoneutralization of PMSG is unlikely to improve the reproductive performance of gilts following a gonadotropin-induced oestrus except in gilts that otherwise would have poor performance.

Multiple births were induced in 20 hinds subjected to a progesterone plus gonadotropin treatment to advance the breeding season by about 4 to 5 weeks. In total, over 2 years, 92 hinds were treated and run with melatonin-treated stags. Of the 59 hinds that calved to the induced oestrus, 39 produced single calves, 19 produced twins and one produced triplets. Birth weight, gestation length, perinatal mortality and growth rate to weaning at ca. 20 weeks of age were compared for singles and twins. There was a significant effect of birth type on birth weight with twins being proportionately 0·30 lighter than singles (6·27 and 8-94 kg; P < 0·001), with a significant interaction between the birth weight of a calf and the sex of its co-twin (P < 0·05); males born as co-twins to females were proportionately 0·18 heavier than their co-twin females (P < 0·06), while in contrast twin male sets were substantially lighter than twin female sets. Gestation lengths were similar for both singles and twins, with significant negative relationships between gestation length and birth weight for both singles and twins, with a 2-day decrease in gestation length for a 1-kg increase in mean birth weight. There was a strong quadratic relationship between perinatal survival and birth weight; the expected mortality rates at 5, 8 and 11 kg birth weight derived from the relationship were 0·39, 0·11 and 0·39 respectively, indicating reduced probability of survival at both low and high birth weights. The regression relationships between weaning weight or growth rate to weaning and birth weight indicate that at the same birth weight, twin-reared calves were about 5 kg lighter than singles at 20 weeks, while an extra 1 kg weight at birth was associated with an extra 2 kg weight at 20 weeks.